Cite
HARVARD Citation
Léger, J. et al. (2013). Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase III study (the PRIMA study). Journal of the peripheral nervous system. 18 (2), pp. 130-140. [Online].